title: On the role of genetic testing for personalized drug overdose management.
authors.affiliation: The Icahn School of Medicine at Mount Sinai, New York, NY, USA, manini.alex@gmail.com.
authors.forename: Alex
authors.initials: A
authors.lastname: Manini
authors.forename: Michelle
authors.initials: M
authors.lastname: Jacobs
authors.forename: David
authors.initials: D
authors.lastname: Vlahov
authors.forename: Yasmin
authors.initials: Y
authors.lastname: Hurd
mesh_terms: D000483:Alleles; D062787:Drug Overdose / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D056726:Genetic Association Studies; D006801:Humans; D009293:Opioid-Related Disorders / Q000235:genetics / Q000378:metabolism; D020641:Polymorphism, Single Nucleotide; D057285:Precision Medicine; D017450:Receptors, Opioid, mu / Q000235:genetics* / Q000378:metabolism; D012720:Severity of Illness Index
chemical_list: C485764:OPRM1 protein, human; D017450:Receptors, Opioid, mu